MEDILYS Laborgesellschaft mbH
MEDILYS Laborgesellschaft mbH is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A phase 3b, prospective, open-label, multicenter, single treatment arm, continuation study of the safety and efficacy of TAK-755 (rADAMTS-13, also know as BAX930/SHP655) in the prophylactic and on-demand treatment of subjects with severe congenital thrombotic thrombocytopenic purpura (cTTP; Upshaw-Schulman Syndrome, or hereditary thrombotic thrombocytopenic purpura)
Sponsor Baxalta Innovations GmbH
- Start (EU)
- Latest update
- Estimated end
A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis with Vonicog Alfa (rVWF) in Children Diagnosed With Severe von Willebrand disease.
Sponsor Takeda Development Center Americas Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF with or without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed with Severe von Willebrand Disease
Sponsor Baxalta Innovations GmbH
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for MEDILYS Laborgesellschaft mbH?
The 2026-10-09 snapshot links MEDILYS Laborgesellschaft mbH to 3 distinct CTIS trials. Recorded services include Laboratory services, Multimer pattern and Ag testing, VWF Multimers. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for MEDILYS Laborgesellschaft mbH?
The most frequently recorded therapeutic areas are Blood Disorders, Genetic and Congenital Disorders. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to MEDILYS Laborgesellschaft mbH conducted?
The linked trials record locations in 8 countries, including Spain, France, Italy, Austria, Belgium. These are trial locations, not confirmed office locations or countries where MEDILYS Laborgesellschaft mbH delivered services.
What can this page tell me about MEDILYS Laborgesellschaft mbH's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under MEDILYS Laborgesellschaft mbH. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- MEDILYS Laborgesellschaft mbH